Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management
- PMID: 20123548
- DOI: 10.1016/S1353-8020(09)70847-8
Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management
Abstract
There is increasing awareness that impulse control disorders (ICDs), including pathological gambling, hyper-sexuality, compulsive eating and buying, can occur as a complication of Parkinson's disease (PD). In addition, other impulsive or compulsive disorders have been reported to occur, including dopamine dysregulation syndrome (DDS) and punding. Case reports and prospective studies have reported an association between ICDs and the use of dopamine receptor agonists at higher doses, and DDS has been associated with L-dopa at higher doses or short-acting dopamine receptor agonists. Risk factors for ICDs include male sex, younger age or younger age at PD onset, a pre-PD history of ICD symptoms, history of substance use or bipolar disorder, and a personality profile characterized by impulsiveness. The management of clinically significant ICD symptoms should consist of modifications to dopamine replacement therapy, particularly dopamine receptor agonists, which is usually associated with an improvement of ICDs. There is no empirical evidence supporting the use of psychiatric drugs for ICDs in PD. Functional neuroimaging studies such as functional MRI and PET can investigate in vivo the neurobiological basis of these pathological behaviours.
Copyright 2009 Elsevier Ltd. All rights reserved.
Similar articles
-
Impulse control disorders in Parkinson's disease: prevalence and possible risk factors.Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S110-3. doi: 10.1016/S1353-8020(09)70794-1. Parkinsonism Relat Disord. 2009. PMID: 20082968
-
Impulse Control and Related Disorders in Parkinson's Disease.Int Rev Neurobiol. 2017;133:679-717. doi: 10.1016/bs.irn.2017.04.006. Epub 2017 Jun 1. Int Rev Neurobiol. 2017. PMID: 28802938 Review.
-
Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease.Clin Neuropharmacol. 2012 Nov-Dec;35(6):261-5. doi: 10.1097/WNF.0b013e31826e6e6d. Clin Neuropharmacol. 2012. PMID: 23123689
-
Addiction-like manifestations and Parkinson's disease: a large single center 9-year experience.Int J Neurosci. 2012 Mar;122(3):145-53. doi: 10.3109/00207454.2011.633722. Epub 2011 Dec 6. Int J Neurosci. 2012. PMID: 22023411
-
[Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].Geriatr Psychol Neuropsychiatr Vieil. 2011 Jun;9(2):227-35. doi: 10.1684/pnv.2011.0275. Geriatr Psychol Neuropsychiatr Vieil. 2011. PMID: 21690031 Review. French.
Cited by
-
Course of Impulse Control Disorder Symptoms in Parkinson's Disease: Deep Brain Stimulation Versus Medications.Mov Disord Clin Pract. 2023 May 5;10(6):903-913. doi: 10.1002/mdc3.13738. eCollection 2023 Jun. Mov Disord Clin Pract. 2023. PMID: 37332637 Free PMC article.
-
Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.Drugs Aging. 2019 Jun;36(6):511-530. doi: 10.1007/s40266-019-00654-z. Drugs Aging. 2019. PMID: 30937878 Review.
-
Dopamine-induced nonmotor symptoms of Parkinson's disease.Parkinsons Dis. 2011;2011:485063. doi: 10.4061/2011/485063. Epub 2011 Apr 11. Parkinsons Dis. 2011. PMID: 21603184 Free PMC article.
-
Effect of Levodopa on Reward and Impulsivity in a Rat Model of Parkinson's Disease.Front Behav Neurosci. 2017 Aug 8;11:145. doi: 10.3389/fnbeh.2017.00145. eCollection 2017. Front Behav Neurosci. 2017. PMID: 28848409 Free PMC article.
-
Subthalamic nucleus stimulation influences expression and suppression of impulsive behaviour in Parkinson's disease.Brain. 2010 Dec;133(Pt 12):3611-24. doi: 10.1093/brain/awq239. Epub 2010 Sep 22. Brain. 2010. PMID: 20861152 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical